<DOC>
	<DOCNO>NCT00426036</DOCNO>
	<brief_summary>This study assess influence severe renal impairment pharmacokinetics licarbazepine glucuronide conjugate single oral administration healthy subject subject stable impaired renal function .</brief_summary>
	<brief_title>Effect Severe Renal Impairment Pharmacokinetics Metabolism Single Administration Licarbazepine</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Male female subjects/patients 1860 year age Body mass index ( BMI ) must within range 18 30 kg/mÂ² . Subjects/patients must weigh minimum 50 kg . Female subjects/patients must either surgically sterilize hysterectomized least 6 month prior screen . Subject/patient must able provide write informed consent prior study participation . Clinically significant abnormal laboratory value screen evaluation baseline reevaluation , patient exclude normally associate severe degree renal impairment primary cause renal insufficiency . Use overthecounter medication herbal / natural supplement 2 week prior dose . ( acetaminophen acceptable , must document Concomitant Medications / NonDrug Therapies page CRF ) . Participation clinical investigation within 4 week prior dose longer required local regulation . Donation loss 400 mL blood within 8 week prior dose amount consider compromise health subject/patient previous history anemia exist . Significant acute illness within two week prior dose . History significant cardiovascular event ( M.I. , angioplasty , angina ) within 6 month study start . A past medical history clinically significant ECG abnormality family history prolong QTinterval syndrome . History hyponatremia . History seizure . Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug renal impairment may jeopardize subject/patient case participation study . The investigator guide history following : inflammatory bowel syndrome , gastritis , ulcer , gastrointestinal rectal bleed gastropathy ( gastroparesis ) enteropathy major gastrointestinal tract surgery gastrectomy , gastroenterostomy , bowel resection clinical evidence pancreatic injury pancreatitis History immunocompromise , include positive HIV ( ELISA Western blot ) test result . A positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . History drug alcohol abuse within 6 month prior dose evidence abuse indicate laboratory assay conduct screen baseline evaluation . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Open-label study , healthy subject , stable impaired renal function , licarbazepine , pharmacokinetics , metabolism , safety .</keyword>
</DOC>